≥2 ARMS/GROUPS: DICHOTOMOUS OUTCOMES (e.g. OR, RR, %death)

UI Author Year Outcome Exposure Categories(e.g., Tertiles)/Intervention Groups Mean Vit D level/dose Mean Ca level/dose No. of Cases (Event) * No. of Non- cases (controls) ** Crude or Adjusted analysis? Outcome Metric (e.g. OR, RR, HR, %) Outcome effect size CI ** P between groups *** P for trend ****
7612803 Braun 1995 Prostate cancer [25(OH)D] Q1 <24.1 nd 7 24 crude OR 1.0 (ref) - nd 0.60
Q2 24.1–29.5 17 25 2.3 0.7–7.8
Q3 29.6–35.4 16 24 2.3 0.7–7.7
Q4 35.5–41.3 4 25 0.6 0.1–2.5
Q5 >41.3 17 24 2.4 0.8–8.2
7612803 Braun 1995 Prostate caner [25(OH)D] Q1 <24.1 nd 7 24 crude OR 1.0 (ref) - nd NS
Q2 >24.1 54 98 1.9 0.7–5.5

Duplicate one row per exposure category or intervention group.

*

Number of subjects with outcome

**

Please choose one and delete the others

***

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

****

P value for testing the linear trend of the OR/RR across different categories or doses

From: Appendix C, Evidence Tables: A-E

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.